"Human Growth Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 191-amino acid polypeptide hormone secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR), also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency.
| Descriptor ID |
D019382
|
| MeSH Number(s) |
D06.472.699.631.525.425.875 D12.644.548.691.525.425.875
|
| Concept/Terms |
Human Growth Hormone- Human Growth Hormone
- Growth Hormone, Human
- hGH (Human Growth Hormone)
- Somatropin (Human)
- Somatotropin (Human)
- Somatropin
|
Below are MeSH descriptors whose meaning is more general than "Human Growth Hormone".
Below are MeSH descriptors whose meaning is more specific than "Human Growth Hormone".
This graph shows the total number of publications written about "Human Growth Hormone" by people in this website by year, and whether "Human Growth Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 2 | 3 |
| 1999 | 2 | 2 | 4 |
| 2000 | 0 | 2 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 0 | 1 |
| 2008 | 3 | 1 | 4 |
| 2011 | 3 | 1 | 4 |
| 2014 | 2 | 2 | 4 |
| 2015 | 1 | 2 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 0 | 3 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2024 | 2 | 0 | 2 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Human Growth Hormone" by people in Profiles.
-
Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review. BMC Endocr Disord. 2022 Dec 21; 22(1):325.
-
Glycogen storage disease type IX and growth hormone deficiency presenting as severe ketotic hypoglycemia. J Pediatr Endocrinol Metab. 2017 Feb 01; 30(2):247-251.
-
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med. 2014 Dec 18; 371(25):2363-74.
-
Idiopathic short stature: decision making in growth hormone use. Indian J Pediatr. 2012 Feb; 79(2):238-43.
-
Inhibition of growth hormone receptor activation by pegvisomant may increase bone density in acromegaly. Horm Metab Res. 2011 Jan; 43(1):55-61.
-
The impact of music on hypermetabolism in critical illness. Curr Opin Clin Nutr Metab Care. 2008 Nov; 11(6):790-4.
-
Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials. Eur J Endocrinol. 2008 Nov; 159(5):517-23.
-
Overture for growth hormone: requiem for interleukin-6? Crit Care Med. 2007 Dec; 35(12):2709-13.
-
Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging. Ann N Y Acad Sci. 2007 Nov; 1119:147-64.
-
Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency. Endocrinology. 2006 Aug; 147(8):3877-88.